-
1
-
-
77958137062
-
IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma
-
White CD, Khurana H, Gnatenko DV, Li Z, Odze RD, Sacks DB and Schmidt VA: IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. BMC Gastroenterol 10: 125, 2010.
-
(2010)
BMC Gastroenterol
, vol.10
, pp. 125
-
-
White, C.D.1
Khurana, H.2
Gnatenko, D.V.3
Li, Z.4
Odze, R.D.5
Sacks, D.B.6
Schmidt, V.A.7
-
2
-
-
36349011806
-
Clinicopathological features of hepatocellular carcinoma evaluated by vascular endothelial growth factor expression
-
DOI 10.1111/j.1440-1746.2006.04790.x
-
Amaoka N, Osada S, Kanematsu M, Imai H, Tomita H, Tokuyama Y, Sakashita F, Nonaka K, Goshima S, Kondo H and Adachi Y: Clinicopathological features of hepatocellular carcinoma evaluated by vascular endothelial growth factor expression. J Gastroenterol Hepatol 22: 2202-2207, 2007. (Pubitemid 350145618)
-
(2007)
Journal of Gastroenterology and Hepatology
, vol.22
, Issue.12
, pp. 2202-2207
-
-
Amaoka, N.1
Osada, S.2
Kanematsu, M.3
Imai, H.4
Tomita, H.5
Tokuyama, Y.6
Sakashita, F.7
Nonaka, K.8
Goshima, S.9
Kondo, H.10
Adachi, Y.11
-
3
-
-
0031022607
-
Expression of HGF, its receptor c-MET, c-MYC, and albumin in cirrhotic and neoplastic human liver tissue
-
Ljubimova JY, Petrovic LM, Wilson SE, Geller SA and Demetriou AA: Expression of HGF, its receptor c-MET, c-MYC, and albumin in cirrhotic and neoplastic human liver tissue. J Histochem Cytochem 45: 79-87, 1997.
-
(1997)
J Histochem Cytochem
, vol.45
, pp. 79-87
-
-
Ljubimova, J.Y.1
Petrovic, L.M.2
Wilson, S.E.3
Geller, S.A.4
Demetriou, A.A.5
-
4
-
-
58849136702
-
Molecular targeted therapy for hepatocellular carcinoma
-
Thomas M: Molecular targeted therapy for hepatocellular carcinoma. J Gastroenterol 44: 136-141, 2009.
-
(2009)
J Gastroenterol
, vol.44
, pp. 136-141
-
-
Thomas, M.1
-
5
-
-
77953669860
-
Microarray-based gene expression analysis of hepatocellular carcinoma
-
Maass T, Sfakianakis I, Staib F, Krupp M, Galle PR and Teufel A: Microarray-based gene expression analysis of hepatocellular carcinoma. Curr Genomics 11: 261-268, 2010.
-
(2010)
Curr Genomics
, vol.11
, pp. 261-268
-
-
Maass, T.1
Sfakianakis, I.2
Staib, F.3
Krupp, M.4
Galle, P.R.5
Teufel, A.6
-
6
-
-
58149352266
-
MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis
-
Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15: 59-67, 2009.
-
(2009)
Nat Med
, vol.15
, pp. 59-67
-
-
Stein, U.1
Walther, W.2
Arlt, F.3
Schwabe, H.4
Smith, J.5
Fichtner, I.6
Birchmeier, W.7
Schlag, P.M.8
-
7
-
-
33847390775
-
C-Met and hepatocyte growth factor: Potential as novel targets in cancer therapy
-
DOI 10.1007/s11912-007-0005-4
-
Sattler M and Salgia R: C-MET and hepatocyte growth factor: potential as novel targets in cancer therapy. Curr Oncol Rep 9: 102-108, 2007. (Pubitemid 46332381)
-
(2007)
Current Oncology Reports
, vol.9
, Issue.2
, pp. 102-108
-
-
Sattler, M.1
Salgia, R.2
-
8
-
-
0025805633
-
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
-
Bottaro, DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF and Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-MET proto-oncogene product. Science 251: 802-804, 1991. (Pubitemid 21926175)
-
(1991)
Science
, vol.251
, Issue.4995
, pp. 802-804
-
-
Bottaro, D.P.1
Rubin, J.S.2
Faletto, D.L.3
Chan, A.M.-L.4
Kmiecik, T.E.5
Vande, W.G.F.6
Aaronson, S.A.7
-
9
-
-
34247142787
-
C-MET is essential for wound healing in the skin
-
Chmielowiec J, Borowiak M, Morkel M, Stradal T, Munz B, Werner S, Wehland J, Birchmeier C and Birchmeier W: c-MET is essential for wound healing in the skin. J Cell Biol 177: 151-162, 2007.
-
(2007)
J Cell Biol
, vol.177
, pp. 151-162
-
-
Chmielowiec, J.1
Borowiak, M.2
Morkel, M.3
Stradal, T.4
Munz, B.5
Werner, S.6
Wehland, J.7
Birchmeier, C.8
Birchmeier, W.9
-
10
-
-
75749153594
-
MACC1-more than metastasis? Facts and predictions about a novel gene
-
Stein U, Dahlmann M and Waither W: MACC1-more than metastasis? Facts and predictions about a novel gene. J Mol Med 88: 11-18, 2009.
-
(2009)
J Mol Med
, vol.88
, pp. 11-18
-
-
Stein, U.1
Dahlmann, M.2
Waither, W.3
-
11
-
-
0030031360
-
Loss of H19 imprinting in esophageal cancer
-
Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480-482, 1996. (Pubitemid 26048601)
-
(1996)
Cancer Research
, vol.56
, Issue.3
, pp. 480-482
-
-
Hibi, K.1
Nakamura, H.2
Hirai, A.3
Fujikake, Y.4
Kasai, Y.5
Akiyama, S.6
Ito, K.7
Takagi, H.8
-
12
-
-
0026318821
-
Coexpression of the stem cell factor and the c-KIT genes in small cell lung cancer
-
Hibi K, Takahashi T, Sekido Y, Ueda R, Hida, T, Ariyoshi Y and Takagi H: Coexpression of the stem cell factor and the c-KIT genes in small cell lung cancer. Oncogene 6: 2291-2296, 1991.
-
(1991)
Oncogene
, vol.6
, pp. 2291-2296
-
-
Hibi, K.1
Takahashi, T.2
Sekido, Y.3
Ueda, R.4
Hida, T.5
Ariyoshi, Y.6
Takagi, H.7
-
14
-
-
70350337085
-
Colon cancer metastasis: MACC1 and MET as metastatic pacemakers
-
Arlt F and Stein U: Colon cancer metastasis: MACC1 and MET as metastatic pacemakers. Int J Biochem Cell Biol 41: 2356-2359, 2009.
-
(2009)
Int J Biochem Cell Biol
, vol.41
, pp. 2356-2359
-
-
Arlt, F.1
Stein, U.2
-
15
-
-
77955792961
-
MACC1 as a marker for advanced colorectal carcinoma
-
Shirahata A, Shinmura K, Kitamura K, Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H and Hibi K: MACC1 as a marker for advanced colorectal carcinoma. Anticancer Res 30: 2689-2692, 2010.
-
(2010)
Anticancer Res
, vol.30
, pp. 2689-2692
-
-
Shirahata, A.1
Shinmura, K.2
Kitamura, K.3
Sakuraba, K.4
Yokomizo, K.5
Goto, T.6
Mizukami, H.7
Saito, M.8
Ishibashi, K.9
Kigawa, G.10
Nemoto, H.11
Hibi, K.12
-
16
-
-
77958605386
-
MACC1 as a marker for peritoneal-disseminated gastric carcinoma
-
Shirahata A, Sakata M, Kitamura Y, Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H and Hibi K: MACC1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res 30: 3441-3444, 2010.
-
(2010)
Anticancer Res
, vol.30
, pp. 3441-3444
-
-
Shirahata, A.1
Sakata, M.2
Kitamura, Y.3
Sakuraba, K.4
Yokomizo, K.5
Goto, T.6
Mizukami, H.7
Saito, M.8
Ishibashi, K.9
Kigawa, G.10
Nemoto, H.11
Hibi, K.12
-
17
-
-
78651317489
-
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
-
Yamamoto K, Imamura H, Matsuyama Y, Kume Y, Ikeda H, Norman GL, Shums Z, Aoki T, Hasegawa K, Beck Y, Sugawara Y and Kokudo N: AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC. J Gastroenterol 45: 1272-1282, 2010.
-
(2010)
J Gastroenterol
, vol.45
, pp. 1272-1282
-
-
Yamamoto, K.1
Imamura, H.2
Matsuyama, Y.3
Kume, Y.4
Ikeda, H.5
Norman, G.L.6
Shums, Z.7
Aoki, T.8
Hasegawa, K.9
Beck, Y.10
Sugawara, Y.11
Kokudo, N.12
|